[et_pb_section fb_built=\u00bb1″ custom_padding_last_edited=\u00bbon|desktop\u00bb next_background_color=\u00bb#ffffff\u00bb admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.25.0″ background_image=\u00bbhttps:\/\/sgan.es\/wp-content\/uploads\/2024\/04\/home_banner_seccion.png\u00bb parallax=\u00bbon\u00bb custom_padding=\u00bb3vw||7vw||false|false\u00bb custom_padding_tablet=\u00bb100px||100px||true\u00bb custom_padding_phone=\u00bb||||true\u00bb bottom_divider_style=\u00bbramp2″ bottom_divider_height=\u00bb250px\u00bb bottom_divider_flip=\u00bbhorizontal\u00bb bottom_divider_height_tablet=\u00bb150px\u00bb bottom_divider_height_phone=\u00bb110px\u00bb bottom_divider_height_last_edited=\u00bbon|phone\u00bb saved_tabs=\u00bball\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_row _builder_version=\u00bb4.16″ global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_text _builder_version=\u00bb4.25.0″ text_font=\u00bbRoboto||||||||\u00bb text_line_height=\u00bb1.8em\u00bb header_font=\u00bbRoboto|700|||||||\u00bb header_text_align=\u00bbcenter\u00bb header_font_size=\u00bb80px\u00bb header_line_height=\u00bb1.2em\u00bb header_3_font=\u00bbRoboto|700||on|||||\u00bb header_3_text_align=\u00bbcenter\u00bb header_3_text_color=\u00bb#ffffff\u00bb header_3_font_size=\u00bb24px\u00bb header_3_letter_spacing=\u00bb10px\u00bb header_3_line_height=\u00bb2em\u00bb text_orientation=\u00bbcenter\u00bb background_layout=\u00bbdark\u00bb module_alignment=\u00bbcenter\u00bb text_font_size_last_edited=\u00bboff|desktop\u00bb header_font_size_tablet=\u00bb40px\u00bb header_font_size_phone=\u00bb32px\u00bb header_font_size_last_edited=\u00bbon|phone\u00bb header_3_font_size_tablet=\u00bb16px\u00bb header_3_font_size_phone=\u00bb14px\u00bb header_3_font_size_last_edited=\u00bbon|phone\u00bb header_3_letter_spacing_tablet=\u00bb5px\u00bb header_3_letter_spacing_phone=\u00bb\u00bb header_3_letter_spacing_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.16″ global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.16″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_code _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb border_width_bottom=\u00bb1px\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb]Inicio<\/a><\/span><\/span>[\/et_pb_code][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.16″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n Registro REXER<\/strong><\/a> Pro: M\u00e1s alla de KT\/V o KT. \u00daltimos d\u00edas del KT\/V<\/strong><\/a> contra: M\u00e1s alla de KT\/V o KT. \u00daltimos d\u00edas del KT\/V<\/strong><\/a> Pro: Di\u00e1lisis frecuentes o nocturna o cuarto d\u00eda frente a di\u00e1lisis incremental<\/strong><\/a> contra: Di\u00e1lisis frecuentes o nocturna o cuarto d\u00eda frente a di\u00e1lisis incremental<\/strong><\/a> An\u00e1lisis de biocompatibilidad a trav\u00e9s de la biopsia peritoneal<\/strong><\/a> \u00abRegistro Enfermedad Poliqu\u00edstica\u00bb en Galicia<\/strong><\/a> Marcadores farmacogen\u00e9ticos en la funci\u00f3n inmunitaria y respuesta a inmunosupresores en el trasplante renal<\/strong><\/a> Linfos T en tolerancia a largo plazo del injerto renal. <\/strong><\/a> Calcificaci\u00f3n vascular marcador subrogado. \u00bfel tratamiento imposible?<\/strong><\/a> Troncalidad: reforma del sistema MIR<\/strong><\/a> [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" PONENCIASInicio<\/a><\/span><\/span>Registro REXER Dra. Encarnaci\u00f3n Bouzas Caama\u00f1o Pro: M\u00e1s alla de KT\/V o KT. \u00daltimos d\u00edas del KT\/V Manuel Molina N\u00fa\u00f1ez contra: M\u00e1s alla de KT\/V o KT. \u00daltimos d\u00edas del KT\/V Jos\u00e9 Luis Teruel Briones Pro: Di\u00e1lisis frecuentes o nocturna o cuarto d\u00eda frente a di\u00e1lisis incremental Rafael P\u00e9rez Garc\u00eda contra: Di\u00e1lisis frecuentes o nocturna […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":33,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":" Registro REXER<\/strong><\/a> Pro: M\u00e1s alla de KT\/V o KT. \u00daltimos d\u00edas del KT\/V<\/strong><\/a> contra: M\u00e1s alla de KT\/V o KT. \u00daltimos d\u00edas del KT\/V<\/strong><\/a> Pro: Di\u00e1lisis frecuentes o nocturna o cuarto d\u00eda frente a di\u00e1lisis incremental<\/strong><\/a> contra: Di\u00e1lisis frecuentes o nocturna o cuarto d\u00eda frente a di\u00e1lisis incremental<\/strong><\/a> An\u00e1lisis de biocompatibilidad a trav\u00e9s de la biopsia peritoneal<\/strong><\/a> \"Registro Enfermedad Poliqu\u00edstica\" en Galicia<\/strong><\/a> Marcadores farmacogen\u00e9ticos en la funci\u00f3n inmunitaria y respuesta a inmunosupresores en el trasplante renal<\/strong><\/a> Linfos T en tolerancia a largo plazo del injerto renal. <\/strong><\/a>
\n Dra. Encarnaci\u00f3n Bouzas Caama\u00f1o<\/p>\n
\n Manuel Molina N\u00fa\u00f1ez<\/p>\n
\n Jos\u00e9 Luis Teruel Briones<\/p>\n
\n Rafael P\u00e9rez Garc\u00eda<\/p>\n
\n Milagros Fern\u00e1ndez Lucas<\/p>\n
\n Jos\u00e9 Antonio Jim\u00e9nez Heffernan<\/p>\n
\n Miguel A. Garc\u00eda Gonz\u00e1lez<\/p>\n
\n Eliecer Coto Garc\u00eda<\/p>\n
\n Jos\u00e9 G\u00f3mez Rial<\/p>\n
\n Jordi Bover Sanjuan<\/p>\n
\n Gema Fern\u00e1ndez Ju\u00e1rez<\/p>\n
\r\n Dra. Encarnaci\u00f3n Bouzas Caama\u00f1o<\/p>\r\n
\r\n Manuel Molina N\u00fa\u00f1ez<\/p>\r\n
\r\n Jos\u00e9 Luis Teruel Briones<\/p>\r\n
\r\n Rafael P\u00e9rez Garc\u00eda<\/p>\r\n
\r\n Milagros Fern\u00e1ndez Lucas<\/p>\r\n
\r\n Jos\u00e9 Antonio Jim\u00e9nez Heffernan<\/p>\r\n
\r\n Miguel A. Garc\u00eda Gonz\u00e1lez<\/p>\r\n
\r\n Eliecer Coto Garc\u00eda<\/p>\r\n
\r\n Jos\u00e9 G\u00f3mez Rial<\/p>\r\n